Remission induction with lenalidomide in a patient with relapsed diffuse large B cell lymphoma of the leg type

被引：0
|
作者：
Abhisek Swaika
David M. Menke
Manoj K. Jain
Taimur Sher
机构：
[1] Mayo Clinic,Department of Hematology
[2] Mayo Clinic,Oncology
[3] Mayo Clinic,Department of Pathology
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Lenalidomide; Bendamustine; Bone Marrow Involvement; Radiological Response; Involve Field Radiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：895 / 896
页数：1
相关论文
共 50 条
  • [1] Remission induction with lenalidomide in a patient with relapsed diffuse large B cell lymphoma of the leg type
    Swaika, Abhisek
    Menke, David M.
    Jain, Manoj K.
    Sher, Taimur
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 895 - 896
  • [2] Lenalidomide monotherapy in relapsed primary cutaneous diffuse large B cell lymphoma-leg type
    P. Savini
    A. Lanzi
    F. G. Foschi
    G. Marano
    G. F. Stefanini
    Annals of Hematology, 2014, 93 : 333 - 334
  • [3] Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B-cell lymphoma, leg type
    Al Dhafiri, Mandi
    de Fontbrune, Flore Sicre
    Marinho, Eduardo
    Deschamps, Lydia
    Di-Lucca, Julie
    Crickx, Beatrice
    Descamps, Vincent
    CLINICAL CASE REPORTS, 2019, 7 (05): : 964 - 967
  • [4] Lenalidomide monotherapy in relapsed primary cutaneous diffuse large B cell lymphoma-leg type
    Savini, P.
    Lanzi, A.
    Foschi, F. G.
    Marano, G.
    Stefanini, G. F.
    ANNALS OF HEMATOLOGY, 2014, 93 (02) : 333 - 334
  • [5] Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type
    Moore, Donald C.
    Soni, Amy C.
    Hu, Bei
    Smith, Elton T.
    Levine, Jonathan
    Moyo, Tamara K.
    Jacobs, Ryan
    Ghosh, Nilanjan
    Park, Steven I.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : E30 - E33
  • [6] Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report
    Zoli, Sabrina
    Pellegrini, Cinzia
    Casadei, Beatrice
    Broccoli, Alessandro
    Argnani, Lisa
    Nanni, Laura
    Stefoni, Vittorio
    Zinzani, Pier Luigi
    CHEMOTHERAPY, 2024, 69 (01) : 23 - 26
  • [7] Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
    Wu, Shaohua
    Gui, Wei
    Su, Liping
    Xi, Yanfeng
    INDIAN JOURNAL OF DERMATOLOGY, 2017, 62 (06) : 568 - +
  • [8] Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B cell lymphoma, leg type
    Di Raimondo, C.
    Martinez, X.
    Abdulla, F.
    Zain, J.
    Rosen, S.
    Querfeld, C.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S43 - S44
  • [9] Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis
    Moore, Donald C.
    Eagers, Keren A.
    Janes, Amanda
    Pineda-Roman, Mauricio
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 239 - 241
  • [10] LENALIDOMIDE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: IS IT A VALID TREATMENT OPTION?
    Mondello, P.
    Steiner, N.
    Willenbacher, W.
    Ferrero, S.
    Marabese, A.
    Pitini, V.
    Cuzzocrea, S.
    Mian, M.
    HAEMATOLOGICA, 2016, 101 : 278 - 278
12345